329 related articles for article (PubMed ID: 12353258)
1. MRI of the tumor microenvironment.
Gillies RJ; Raghunand N; Karczmar GS; Bhujwalla ZM
J Magn Reson Imaging; 2002 Oct; 16(4):430-50. PubMed ID: 12353258
[TBL] [Abstract][Full Text] [Related]
2. Impact of hypoxia and the metabolic microenvironment on radiotherapy of solid tumors. Introduction of a multi-institutional research project.
Zips D; Adam M; Flentje M; Haase A; Molls M; Mueller-Klieser W; Petersen C; Philbrook C; Schmitt P; Thews O; Walenta S; Baumann M
Strahlenther Onkol; 2004 Oct; 180(10):609-15. PubMed ID: 15480508
[TBL] [Abstract][Full Text] [Related]
3. Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging.
Bains LJ; Baker JH; Kyle AH; Minchinton AI; Reinsberg SA
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):957-65. PubMed ID: 19480975
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cell death in the tumor microenvironment.
Wouters BG; Koritzinsky M; Chiu RK; Theys J; Buijsen J; Lambin P
Semin Radiat Oncol; 2003 Jan; 13(1):31-41. PubMed ID: 12520462
[TBL] [Abstract][Full Text] [Related]
5. MRI for identification of progression in brain tumors: from morphology to function.
Weber MA; Giesel FL; Stieltjes B
Expert Rev Neurother; 2008 Oct; 8(10):1507-25. PubMed ID: 18928344
[TBL] [Abstract][Full Text] [Related]
6. Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications.
Gallez B; Baudelet C; Jordan BF
NMR Biomed; 2004 Aug; 17(5):240-62. PubMed ID: 15366026
[TBL] [Abstract][Full Text] [Related]
7. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
8. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
9. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
[TBL] [Abstract][Full Text] [Related]
10. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.
Vaupel P; Kallinowski F; Okunieff P
Cancer Res; 1989 Dec; 49(23):6449-65. PubMed ID: 2684393
[TBL] [Abstract][Full Text] [Related]
11. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment.
Cuenod CA; Fournier L; Balvay D; Guinebretière JM
Abdom Imaging; 2006; 31(2):188-93. PubMed ID: 16447089
[TBL] [Abstract][Full Text] [Related]
12. [Development of new methods of magnetic resonance for the characterization of oxygenation and perfusion of tumors. Diagnostic and therapeutic applications].
Gallez B
Bull Mem Acad R Med Belg; 2007; 162(5-6):323-30. PubMed ID: 18405002
[TBL] [Abstract][Full Text] [Related]
13. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging.
Graff BA; Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2005 Mar; 21(3):272-81. PubMed ID: 15723369
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced magnetic resonance imaging of central nervous system tumors: agents, mechanisms, and applications.
Essig M; Weber MA; von Tengg-Kobligk H; Knopp MV; Yuh WT; Giesel FL
Top Magn Reson Imaging; 2006 Apr; 17(2):89-106. PubMed ID: 17198225
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironmental physiology and its implications for radiation oncology.
Vaupel P
Semin Radiat Oncol; 2004 Jul; 14(3):198-206. PubMed ID: 15254862
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
Rosen MA; Schnall MD
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM
Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907
[TBL] [Abstract][Full Text] [Related]
18. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
19. In vivo determination of tumor oxygenation during growth and in response to carbogen breathing using 15C5-loaded alginate capsules as fluorine-19 magnetic resonance imaging oxygen sensors.
Nöth U; Rodrigues LM; Robinson SP; Jork A; Zimmermann U; Newell B; Griffiths JR
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):909-19. PubMed ID: 15465209
[TBL] [Abstract][Full Text] [Related]
20. Assessment of tumor tissue oxygenation: agents, methods and clinical significance.
Pauwels EK; Mariani G
Drug News Perspect; 2007 Dec; 20(10):619-26. PubMed ID: 18301796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
